Balin-Gauthier, Diane <br/><br/>
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jun 2006 
 - 709-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-005-0123-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Line, Tumor<br/>Cetuximab<br/>Colorectal Neoplasms--drug therapy<br/>Drug Synergism<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Phosphorylation<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays